Journal article
Validation of putative apicoplast-targeting drugs using a chemical supplementation assay in cultured human malaria parasites
T Uddin, GI McFadden, CD Goodman
Antimicrobial Agents and Chemotherapy | AMER SOC MICROBIOLOGY | Published : 2018
DOI: 10.1128/AAC.01161-17
Abstract
Malaria parasites contain a relict plastid, the apicoplast, which is considered an excellent drug target due to its bacterial-like ancestry. Numerous parasiticidals have been proposed to target the apicoplast, but few have had their actual targets substantiated. Isopentenyl pyrophosphate (IPP) production is the sole required function of the apicoplast in the blood stage of the parasite life cycle, and IPP supplementation rescues parasites from apicoplast-perturbing drugs. Hence, any drug that kills parasites when IPP is supplied in culture must have a nonapicoplast target. Here, we use IPP supplementation to discriminate whether 23 purported apicoplasttargeting drugs are on- or off-target. W..
View full abstractRelated Projects (2)
Grants
Awarded by Australian Research Council
Funding Acknowledgements
This work was supported by an Australian National Health and Medical Research Project Grant and an Australian Research Council Discovery Project Grant and Laureate Fellowship.